MedPath

NeuroQore Inc

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:1

Trial Phases

1 Phases

Not Applicable:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
2 (100.0%)

NQ TMS for MDD Therapy Using 1 Day x 3 Sessions Protocol for Adult Patient

Not Applicable
Completed
Conditions
Major Depressive Disorder (MDD)
First Posted Date
2025-01-14
Last Posted Date
2025-05-13
Lead Sponsor
NeuroQore Inc.
Target Recruit Count
50
Registration Number
NCT06772987
Locations
🇺🇸

LGTC Group, San Jose, California, United States

Linear Asymmetric rTMS in Adolescent Treatment-Resistant Depression: Tolerability of Treatment Durations Ranging From Ten Days to One Day

Not Applicable
Conditions
Treatment Resistant Depression
First Posted Date
2019-06-14
Last Posted Date
2021-09-01
Lead Sponsor
NeuroQore Inc.
Target Recruit Count
19
Registration Number
NCT03986658
Locations
🇨🇦

Children's Hospital of Eastern Ontario, Ottawa, Ontario, Canada

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.